Glaukos (GKOS) Property, Plant & Equipment (Net) Growth (1y) (2015 - 2026)
Glaukos (GKOS) Property, Plant & Equipment (Net) Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.36 Bn | 194.75 Bn | 7.27 Bn | 12.44% |
| 2 | Stryker | 129.99 Bn | 126.52 Bn | 4.50 Bn | 6.92% |
| 3 | Medtronic | 120.03 Bn | 110.81 Bn | 6.41 Bn | 8.48% |
| 4 | Boston Scientific | 74.30 Bn | 73.76 Bn | 3.85 Bn | 19.21% |
| 5 | Edwards Lifesciences | 52.61 Bn | 48.36 Bn | 1.35 Bn | 6.67% |
| 6 | Dexcom | 34.71 Bn | 32.76 Bn | 830.00 Mn | 8.23% |
| 7 | GE HealthCare Technologies | 34.24 Bn | 32.13 Bn | 2.18 Bn | 6.21% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | -1.40% |
| 9 | Steris | 23.30 Bn | 22.81 Bn | 684.20 Mn | 5.69% |
| 10 | Glaukos | 11.19 Bn | 11.08 Bn | 151.59 Mn | 0.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.27% |
| Mar 31, 2026 | 16.14% |
| Dec 31, 2025 | 15.72% |
| Sep 30, 2025 | 12.54% |
| Jun 30, 2025 | 11.56% |
| Mar 31, 2025 | -4.96% |
| Dec 31, 2024 | -5.18% |
| Sep 30, 2024 | -4.36% |
| Jun 30, 2024 | -2.38% |
| Mar 31, 2024 | 3.59% |
| Dec 31, 2023 | 9.33% |
| Sep 30, 2023 | 18.06% |
| Jun 30, 2023 | 26.88% |
| Mar 31, 2023 | 31.62% |
| Dec 31, 2022 | 36.88% |
| Sep 30, 2022 | 43.60% |
| Jun 30, 2022 | 48.81% |
| Mar 31, 2022 | 72.48% |
| Dec 31, 2021 | 187.28% |
| Sep 30, 2021 | 159.74% |